Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (32)

2024

  1. Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology

    PLoS Computational Biology, Vol. 20, Núm. 2

  2. The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis

    American Journal of Hematology

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  3. Lifestyles, arterial aging, and its relationship with the intestinal and oral microbiota (MIVAS III study): a research protocol for a cross-sectional multicenter study

    Frontiers in public health, Vol. 11, pp. 1164453

2022

  1. ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S199

  2. CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  3. Retinal blood vessel calibre and vascular ageing in a general Spanish population: A EVA study

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

  4. Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis

    Medicina Clinica, Vol. 158, Núm. 11, pp. 503-508

2021

  1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

  2. Gut microbiota composition and arterial stiffness measured by pulse wave velocity: Case-control study protocol (MIVAS study)

    BMJ Open, Vol. 11, Núm. 2

  3. The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment

    Diagnostics, Vol. 11, Núm. 5

2020

  1. Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA Study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 43-52

2019

  1. Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation

    Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162

  2. Clinical, cytogenetic, and molecular findings in a patient with ring chromosome 4: Case report and literature review

    BMC Medical Genomics, Vol. 12, Núm. 1

  3. Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency

    PLoS ONE, Vol. 14, Núm. 5

2018

  1. Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries

    British Journal of Haematology, Vol. 181, Núm. 3, pp. 350-359

  2. HARMONY: Anonimización aplicada al campo de la investigación médica

    Revista SIC: ciberseguridad, seguridad de la información y privacidad, Vol. 27, Núm. 132, pp. 88-89

  3. La Alianza HARMONY: La importancia de incorporar las nuevas tecnologías a los sistemas sanitarios

    I+S: Revista de la Sociedad Española de Informática y Salud, Núm. 130, pp. 65-68

2017

  1. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts

    Leukemia Research, Vol. 56, pp. 82-87